Study Of Concurrent Durvalumab And Radiation Therapy Followed By Adjuvant Durvalumab In Patients With Urothelial Cancer (T2-4 N0-2 M0) Of The Bladder (BTCRC GU15-023)

Study Of Concurrent Durvalumab And Radiation Therapy Followed By Adjuvant Durvalumab In Patients With Urothelial Cancer (T2-4 N0-2 M0) Of The Bladder (BTCRC GU15-023)

Trial Category:
Genitourinary
Phase
I
Contact(s)
Mary Beth Wilwerding, RN
Phone
402-991-8070
Fax
402-991-8850
Location(s)
Methodist Estabrook Cancer Center, Omaha, NE
 
 
Become a NOS Member Today!
 

Platinum Corporate Members

Gold Corporate Members